Pozelimab Uses, Dosage, Side Effects and more
Pozelimab is under investigation in clinical trial NCT03115996 (Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN3918 in Healthy Volunteers).
| Trade Name | Pozelimab |
| Generic | Pozelimab |
| Pozelimab Other Names | Pozelimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
